Abstract Background: Purified cannabidiol (CBD), a non-psychoactive phytocannabinoid, has gained regulatory approval to treat intractable childhood epilepsies. Despite this, artisanal…
Abstract The therapeutic potential of cannabidiol (CBD), a non-psychtropic component of the Cannabis sativa plant, is substantiated more and more.…
Abstract The use of medical cannabis (MC) to treat cancer-related symptoms is rising. However, there is a lack of long-term…
Abstract The decriminalization and legalization of cannabis has paved the way for investigations into the potential of the use of…
Abstract There is growing evidence to support the involvement of nutrients and biostimulants in plant secondary metabolism. Therefore, this study…
Abstract In recent years, interest in Cannabis sativa L. has been rising, as legislation is moving in the right direction.…
Abstract Cannabis (Cannabis sativa L.) has a rich history of human use, and the therapeutic importance of compounds produced by…
Abstract Currently, there are no pharmacological treatments able to reverse nigral degeneration in Parkinson’s disease (PD), hence the unmet need…
Abstract Purpose: Cannabichromene (CBC) is a phytocannabinoid commonly found in cannabis, yet its acute post-dose pharmacokinetics (PK) have not been…
Abstract The possible evolutionary trend of COVID-19 in South Africa was investigated by comparing the genome of SARS-CoV-2 isolated from…